Dr. Roslyn Bernstein Mannon is a Professor of Medicine and Surgery, and Director of Transplant Research at the University of Alabama at Birmingham. Dr. Mannon received her MD from Duke University School of Medicine, completed her Internal Medicine and Nephrology training at Duke, and was the Chief Medical Resident. Her laboratory research focuses on mechanisms of chronic graft injury using in vitro and rodent models of kidney transplantation and CNI nephrotoxicity. She is site PI for the NIH/NIAID Clinical Trials in Organ Transplantation, and a member of the CTOT Steering Committee. She has published over 100 peer reviewed publications on the mechanisms of chronic allograft injury, ischemic injury following organ procurement, and other medical complications after transplantation. She was a past-president of AST.

Dr. Roslyn B Mannon, a past-president of AST, is a Professor of Medicine and Director of Research for the Comprehensive Transplant Institute at UAB. A graduate of Duke University Medical School, she completed Internal Medicine and Nephrology training at Duke. Her laboratory research focuses on mechanisms of chronic graft injury using in vitro and rodent models of kidney transplantation and CNI nephrotoxicity. She is site PI for the Clinical Trials in Organ Transplantation, and a member of the CTOT Steering Committee. She has published over 100 peer reviewed publications on the mechanisms of chronic allograft injury and therapeutics in transplantation.